Data from a new survey, conducted by Pfizer, found that a patient’s perception of their rheumatoid arthritis (RA) and its treatment, as well as their relationship with their healthcare professional (HCP), can impact the management of their disease. Pfizer announced initial results from the global survey, called RA NarRAtive, consisting …